{
  "docId": "019dd923-5ca1-7489-b638-195715167efa",
  "docSlug": "c4a00c854103dba5",
  "documentTitle": "Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies",
  "authorId": "LEK",
  "authorName": "L.E.K.",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 17,
  "pageCount": 31,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "kpi_dashboard",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Data from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.",
  "elementsJson": [
    "headline_text",
    "bar_chart_vertical",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-195715167efa/17",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-195715167efa",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-195715167efa.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-195715167efa#slide-17",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "~50% NRDL products face some level of prescription restriction",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-c7cb-728d-8e7c-ebf25b50f93d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.35,
        "y": 0.42
      },
      "kind": "chart",
      "text": "Public L3 vs L2 comparison",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2d0280f4-13c8-4067-ac20-c3f2e71d1e4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.03,
        "y": 0.42
      },
      "kind": "chart",
      "text": "2021 vs 2022 comparison",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "630ef93a-0ae2-4d7c-bd16-d065f6e0af7a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.67,
        "y": 0.42
      },
      "kind": "chart",
      "text": "Tier 1 vs Tier 2&3 cities comparison",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84b8e2dd-42a2-45f8-a941-f06332695ce0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Percentage of respondents: 51%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-c7cb-728d-8e7c-ee4534582acb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.03,
        "y": 0.86
      },
      "kind": "paragraph",
      "text": "Note: Question: Once NRDL-negotiation drugs are on the hospital formulary, are there any barriers to prescribing the drug? ... Responses with \"No. NRDL-negotiated drugs can be prescribed without any limits\"",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb93d220-f7ec-4730-b347-e880178bc95d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.03,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Source: L.E.K. 2021, 2022 APAC Hospital Priorities Survey",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43e3d99c-1bdd-4676-9f10-fed8d0f25e59",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Prescription limit for NRDL products has reduced meaningfully, with half of the products without (so half of the products face) some level of restrictions / cap",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90ecb4a5-5ae4-4e89-959b-943fe595c0d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.26,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "title",
      "text": "NRDL and VBP impact",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b543362c-6c1f-4f76-9805-e3dfb4a6fc75",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [
    {
      "metricRaw": "Percentage of respondents",
      "numberRaw": "51%",
      "numberKind": "percent",
      "actionTitle": "Prescription limit for NRDL products has reduced meaningfully, with half of the products without (so half of the products face) some level of restrictions / cap",
      "calloutText": "~50% NRDL products face some level of prescription restriction",
      "numberScale": null,
      "numberValue": 51,
      "metricFamily": "survey_sentiment",
      "numberCurrency": null
    }
  ],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 7,
      "beatId": "fecabda7-2ea5-4e37-ba42-495f0806ad85",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The key findings and data tables provide evidence of the hospital priorities and trends.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 7,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "44e2be0e-cbbb-40e0-8c98-4c856241947d",
      "evidence": "The key findings and data tables provide a comprehensive overview of hospital priorities.",
      "position": 0,
      "objective": "What are the key priorities and trends in hospital management?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.8,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}